Price $107.57 |
Market Cap
1.79B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
49.4
|
P/B
3.31
|
P/S
2.21
|
Dividend %
-
|
|
P/CF
13.6
|
P/FCF
28.1
|
Op. Cash Flow
67K
|
FCF
3.8
|
|
Op. Margin
5.60%
|
Net Margin
4.10%
|
ROE
6.40%
|
ROI
5.10%
|
|
ROA
4.70%
|
EPS Growth
48.40%
|
Current Ratio
3.1
|
Debt/Equity
12.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $20.95 | - | - | 776.4M | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.91 | - | - | 959.8M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.92 | - | - | 12.34B | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.73 | - | - | 62.5M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $8.36 | - | - | 17.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
